Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-01

Clinical Trial Update: Berberine, Chlorogenic Acid and Tocotrienols in Menopause-associated Dyslipidemia [NA]

View source ↗

Summary

Completed clinical trial evaluating berberine, chlorogenic acid, and tocotrienols for menopause-associated dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine (berberine)
  • Chlorogenic acid (chlorogenic acid)
  • Tocotrienols (tocotrienols)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Dyslipidemia | NA | Status: COMPLETED